Medical Condition News

RSS

BioIVT announces research into mechanisms involved in cholestatic drug-induced liver injury

BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury has been published in Applied In Vitro Toxicology.

10 Sep 2018

Individualized therapies targeting specific features show promise in transforming cancer treatment

Individualized therapies that target the specific genetic features of tumors have the potential to transform cancer diagnosis, treatment and care.

10 Sep 2018

World Sepsis Day

A series of articles and thought leader interviews for World Sepsis Day on the 10th September 2018, aiming to raise awareness and improve understanding.

10 Sep 2018

Raising Awareness of Sepsis

An interview with Dr. Steven Simpson, MD, discussing the importance of raising awareness of the signs and symptoms of sepsis, and how Sepsis Alliance is helping to reduce the number of deaths caused by sepsis in the USA.

10 Sep 2018

Researchers develop new testing device to better diagnose dizziness

Half of over-65s suffer from dizziness and problems with balance. But some tests to identify the causes of such problems are painful and can risk hearing damage.

10 Sep 2018

People with acute critical illness have increased risk of kidney complications and death

Acute critical illness in people without previous renal disease puts them at risk of kidney complications as well as death, according to a study in published in CMAJ

10 Sep 2018

Social support is most decisive factor linked with life satisfaction in young cancer patients

Among adolescents and young adults with cancer, social support was the most decisive factor associated with life satisfaction.

10 Sep 2018

Scientists invent new blood pressure app that gives accurate readings using iPhone

Michigan State University has invented a proof-of-concept blood pressure app that can give accurate readings using an iPhone - with no special equipment.

10 Sep 2018

Novel finding that links ALS/ataxia to cellular stress opens door to new treatment approaches

Few treatments exist for neurodegenerative diseases that progressively rob a person's ability to move and think, yet the results of a new study could potentially open additional approaches for exploration.

7 Sep 2018

RUDN biochemists describe previously unknown mechanism of autoimmunity regulation

The ability of a human body to resist pathogenic factors is under control of immune cells, the most important of which are lymphocytes.

7 Sep 2018

New guidelines for TBI incorporate insights from rehabilitation professionals

Clinical practice guidelines play a critical role in promoting quality care for patients with traumatic brain injury.

7 Sep 2018

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

7 Sep 2018

CNS releases new clinical practice guidelines for thoracolumbar spine trauma

The Congress of Neurological Surgeons has issued new clinical practice guidelines on the evaluation and treatment of patients with thoracolumbar spine trauma.

7 Sep 2018

Metabolic dysfunction drives chronic illness

Much of modern Western medicine is based upon the treatment of acute, immediate harm, from physical injury to infections, from broken bones and the common cold to heart and asthma attacks.

7 Sep 2018

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.

7 Sep 2018

EC approves update of INVOKANA and VOKANAMET labeling to include changes to indication statement

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted approval to update the INVOKANA® and VOKANAMET® labeling to include changes to the indication statement for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

7 Sep 2018

Medical Condition News

BioIVT announces research into mechanisms involved in cholestatic drug-induced liver injury

Individualized therapies targeting specific features show promise in transforming cancer treatment

World Sepsis Day

Raising Awareness of Sepsis

Researchers develop new testing device to better diagnose dizziness

People with acute critical illness have increased risk of kidney complications and death

Social support is most decisive factor linked with life satisfaction in young cancer patients

Scientists invent new blood pressure app that gives accurate readings using iPhone

Novel finding that links ALS/ataxia to cellular stress opens door to new treatment approaches

RUDN biochemists describe previously unknown mechanism of autoimmunity regulation

New guidelines for TBI incorporate insights from rehabilitation professionals

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

CNS releases new clinical practice guidelines for thoracolumbar spine trauma

Metabolic dysfunction drives chronic illness

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

EC approves update of INVOKANA and VOKANAMET labeling to include changes to indication statement

Daytime sleepiness found to be a potential risk factor for Alzheimer’s disease

Insulin’s high cost leads to deadly rationing

Scientists discover key aspect in the development of multiple sclerosis

Fiber strengthens intestinal barrier and counteracts gastrointestinal problems

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News